Logo image of DIM.PA

SARTORIUS STEDIM BIOTECH (DIM.PA) Stock Fundamental Analysis

Europe - EPA:DIM - FR0013154002 - Common Stock

198.35 EUR
-0.25 (-0.13%)
Last: 10/6/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to DIM. DIM was compared to 20 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of DIM get a neutral evaluation. Nothing too spectacular is happening here. DIM is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year DIM was profitable.
DIM had a positive operating cash flow in the past year.
DIM had positive earnings in each of the past 5 years.
Each year in the past 5 years DIM had a positive operating cash flow.
DIM.PA Yearly Net Income VS EBIT VS OCF VS FCFDIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

The Return On Assets of DIM (2.71%) is worse than 65.00% of its industry peers.
DIM's Return On Equity of 5.63% is on the low side compared to the rest of the industry. DIM is outperformed by 60.00% of its industry peers.
DIM has a worse Return On Invested Capital (4.60%) than 60.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DIM is above the industry average of 7.27%.
The 3 year average ROIC (10.41%) for DIM is well above the current ROIC(4.60%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.71%
ROE 5.63%
ROIC 4.6%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
DIM.PA Yearly ROA, ROE, ROICDIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

DIM has a Profit Margin (7.78%) which is comparable to the rest of the industry.
DIM's Profit Margin has declined in the last couple of years.
DIM's Operating Margin of 14.71% is in line compared to the rest of the industry. DIM outperforms 50.00% of its industry peers.
In the last couple of years the Operating Margin of DIM has declined.
DIM's Gross Margin of 44.63% is fine compared to the rest of the industry. DIM outperforms 65.00% of its industry peers.
DIM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.71%
PM (TTM) 7.78%
GM 44.63%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
DIM.PA Yearly Profit, Operating, Gross MarginsDIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DIM is still creating some value.
DIM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DIM has more shares outstanding
DIM has a better debt/assets ratio than last year.
DIM.PA Yearly Shares OutstandingDIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DIM.PA Yearly Total Debt VS Total AssetsDIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

DIM has an Altman-Z score of 4.01. This indicates that DIM is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.01, DIM is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
The Debt to FCF ratio of DIM is 5.98, which is a neutral value as it means it would take DIM, 5.98 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.98, DIM is in line with its industry, outperforming 45.00% of the companies in the same industry.
DIM has a Debt/Equity ratio of 0.71. This is a neutral value indicating DIM is somewhat dependend on debt financing.
DIM has a worse Debt to Equity ratio (0.71) than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 5.98
Altman-Z 4.01
ROIC/WACC0.55
WACC8.43%
DIM.PA Yearly LT Debt VS Equity VS FCFDIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.91 indicates that DIM should not have too much problems paying its short term obligations.
The Current ratio of DIM (1.91) is better than 85.00% of its industry peers.
A Quick Ratio of 1.18 indicates that DIM should not have too much problems paying its short term obligations.
DIM has a Quick ratio of 1.18. This is in the lower half of the industry: DIM underperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.18
DIM.PA Yearly Current Assets VS Current LiabilitesDIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

7

3. Growth

3.1 Past

DIM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.91%, which is quite impressive.
DIM shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.19% yearly.
DIM shows a small growth in Revenue. In the last year, the Revenue has grown by 5.44%.
The Revenue has been growing by 14.05% on average over the past years. This is quite good.
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%

3.2 Future

The Earnings Per Share is expected to grow by 22.23% on average over the next years. This is a very strong growth
DIM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.45% yearly.
EPS Next Y27.61%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
EPS Next 5Y22.23%
Revenue Next Year9.03%
Revenue Next 2Y9.51%
Revenue Next 3Y10.23%
Revenue Next 5Y10.45%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DIM.PA Yearly Revenue VS EstimatesDIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
DIM.PA Yearly EPS VS EstimatesDIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DIM is valuated quite expensively with a Price/Earnings ratio of 48.03.
Based on the Price/Earnings ratio, DIM is valued a bit more expensive than 75.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of DIM to the average of the S&P500 Index (27.90), we can say DIM is valued expensively.
Based on the Price/Forward Earnings ratio of 36.96, the valuation of DIM can be described as expensive.
Based on the Price/Forward Earnings ratio, DIM is valued a bit more expensive than 75.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.36, DIM is valued quite expensively.
Industry RankSector Rank
PE 48.03
Fwd PE 36.96
DIM.PA Price Earnings VS Forward Price EarningsDIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

80.00% of the companies in the same industry are cheaper than DIM, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DIM indicates a slightly more expensive valuation: DIM is more expensive than 65.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 38.88
EV/EBITDA 29.14
DIM.PA Per share dataDIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

DIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
DIM's earnings are expected to grow with 23.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.74
PEG (5Y)11.45
EPS Next 2Y23.83%
EPS Next 3Y23.3%

More info and screens

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.36%, DIM is not a good candidate for dividend investing.
DIM's Dividend Yield is comparable with the industry average which is at 0.71.
Compared to an average S&P500 Dividend Yield of 2.44, DIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.36%

5.2 History

The dividend of DIM has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
DIM.PA Yearly Dividends per shareDIM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

DIM pays out 29.77% of its income as dividend. This is a sustainable payout ratio.
DIM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP29.77%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
DIM.PA Yearly Income VS Free CF VS DividendDIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DIM.PA Dividend Payout.DIM.PA Dividend Payout, showing the Payout Ratio.DIM.PA Dividend Payout.PayoutRetained Earnings

More info and screens

SARTORIUS STEDIM BIOTECH

EPA:DIM (10/6/2025, 7:00:00 PM)

198.35

-0.25 (-0.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)07-22 2025-07-22/bmo
Earnings (Next)10-16 2025-10-16
Inst Owners11.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.31B
Analysts81.11
Price Target239.39 (20.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.36%
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP29.77%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.2%
Min EPS beat(2)10.22%
Max EPS beat(2)22.18%
EPS beat(4)3
Avg EPS beat(4)8.6%
Min EPS beat(4)-5.62%
Max EPS beat(4)22.18%
EPS beat(8)3
Avg EPS beat(8)-10.02%
EPS beat(12)3
Avg EPS beat(12)-13.27%
EPS beat(16)5
Avg EPS beat(16)-12.35%
Revenue beat(2)2
Avg Revenue beat(2)1.91%
Min Revenue beat(2)0.3%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)3.52%
Revenue beat(8)5
Avg Revenue beat(8)-0.72%
Revenue beat(12)5
Avg Revenue beat(12)-1.47%
Revenue beat(16)8
Avg Revenue beat(16)12%
PT rev (1m)0.2%
PT rev (3m)-1.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.15%
EPS NY rev (1m)0%
EPS NY rev (3m)2.93%
Revenue NQ rev (1m)4.65%
Revenue NQ rev (3m)2.36%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE 48.03
Fwd PE 36.96
P/S 6.67
P/FCF 38.88
P/OCF 24.5
P/B 4.82
P/tB N/A
EV/EBITDA 29.14
EPS(TTM)4.13
EY2.08%
EPS(NY)5.37
Fwd EY2.71%
FCF(TTM)5.1
FCFY2.57%
OCF(TTM)8.1
OCFY4.08%
SpS29.76
BVpS41.13
TBVpS-4.66
PEG (NY)1.74
PEG (5Y)11.45
Profitability
Industry RankSector Rank
ROA 2.71%
ROE 5.63%
ROCE 5.78%
ROIC 4.6%
ROICexc 5.12%
ROICexgc 15.67%
OM 14.71%
PM (TTM) 7.78%
GM 44.63%
FCFM 17.14%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexcg growth 3Y-36.77%
ROICexcg growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score7
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 5.98
Debt/EBITDA 3.84
Cap/Depr 93.43%
Cap/Sales 10.07%
Interest Coverage 2.82
Cash Conversion 106.77%
Profit Quality 220.28%
Current Ratio 1.91
Quick Ratio 1.18
Altman-Z 4.01
F-Score7
WACC8.43%
ROIC/WACC0.55
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
EPS Next Y27.61%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
EPS Next 5Y22.23%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%
Revenue Next Year9.03%
Revenue Next 2Y9.51%
Revenue Next 3Y10.23%
Revenue Next 5Y10.45%
EBIT growth 1Y7.47%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year92.67%
EBIT Next 3Y37.11%
EBIT Next 5Y27.7%
FCF growth 1Y202.01%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y16.41%
OCF growth 3Y5.11%
OCF growth 5Y21.32%